We are live on ! Find out more
ASLN

ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN

Delisted

ASLN was delisted on the 18th of July, 2024.

Back to rankings

1 hedge funds and large institutions have $95 invested in ASLAN Pharmaceuticals Limited American Depositary Shares in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

95% less funds holding

Funds holding: 19 → 1 (-18)

100% less capital invested

Capital invested by funds: $892K → $95 (-$891K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 18

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
-18
Holders Change %
-94.74%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$315K
2
VCIM
Velan Capital Investment Management
Georgia
-$188K
3
SC
Shay Capital
New York
-$120K
4
SCM
Sio Capital Management
New York
-$76.2K
5
Renaissance Technologies
Renaissance Technologies
New York
-$41.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
RhumbLine Advisers
1
RhumbLine Advisers
Massachusetts
$95 -$4 -2 -1%
BI
2
BVF Inc
California
– -$315K -131,250 Closed
VCIM
3
Velan Capital Investment Management
Georgia
– -$188K -78,125 Closed
SC
4
Shay Capital
New York
– -$120K -50,000 Closed
SCM
5
Sio Capital Management
New York
– -$76.2K -31,769 Closed
Renaissance Technologies
6
Renaissance Technologies
New York
– -$41.7K -17,358 Closed
SSA
7
Schonfeld Strategic Advisors
New York
– -$37.3K -15,538 Closed
Citadel Advisors
8
Citadel Advisors
Florida
– -$35.3K -14,709 Closed
MG
9
Marex Group
– -$25K -10,433 Closed
Millennium Management
10
Millennium Management
New York
– -$13.9K -5,796 Closed
TSS
11
Two Sigma Securities
New York
– -$9.66K -4,027 Closed
OBWG
12
Onyx Bridge Wealth Group
New York
– -$6.82K -2,841 Closed
WW
13
Waterfront Wealth
Kansas
– -$6.82K -2,840 Closed
UBS Group
14
UBS Group
Switzerland
– -$4.93K -2,056 Closed
Bank of America
15
Bank of America
North Carolina
– -$4.2K -1,749 Closed
XT
16
XTX Topco
Cayman Islands
– -$4.14K -1,726 Closed
Morgan Stanley
17
Morgan Stanley
New York
– -$2.61K -1,088 Closed
Simplex Trading
18
Simplex Trading
Illinois
– -$412 -220 Closed
Qube Research & Technologies (QRT)
19
Qube Research & Technologies (QRT)
United Kingdom
– -$10 -4 Closed

ASLN Hedge Fund Activity: Q3 2024 in Review

1 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) for Q3 2024, worth a combined $95 — down 100% from $892K a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of ASLN and 0 opened new positions — a net loss of 18 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was BVF Inc, exiting entirely with an estimated $315K sold.

  • 1 institutional investor held ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) as of Q3 2024, down from 19 in Q2 2024.
  • Funds reported $95 of ASLAN Pharmaceuticals Limited American Depositary Shares stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new ASLAN Pharmaceuticals Limited American Depositary Shares positions in Q3 2024 and 18 closed out, a net change of -18 holders.
  • The largest ASLAN Pharmaceuticals Limited American Depositary Shares seller in Q3 2024 was BVF Inc, an estimated $315K sold.

Based on aggregated 13F filings for Q3 2024.